Literature DB >> 25668710

[Can the implantable collamer lens with AquaPORT technology safely prevent an angle block? Early experiences in the Homburg/Saar refractive surgery center].

T Tsintarakis1, T Eppig, A Langenbucher, B Seitz, M El-Husseiny.   

Abstract

INTRODUCTION: The spectrum of surgical correction of high myopia has been broadened through surgical implantation of phakic intraocular lenses (pIOL) as a possible alternative to corneal refractive surgery. The purpose of the present study was to evaluate the intraoperative and early postoperative results of patients after the implantation of a posterior chamber implantable collamer (ICL) pIOL to correct high myopia. In particular the study tried to answer the question whether the AquaPORT technology can safely prevent angle closure glaucoma. PATIENTS AND METHODS: From March 2012 to November 2013, 24 eyes from 12 patients suffering from a high myopia (-8.75 ± 4.37 D, maximum -22.75 D) underwent implantation of a posterior chamber implantable phakic collamer intraocular lens (ICL) with AquaPORT technology in the Homburg/Saar refractive surgery center. The implantable ICL consists of collamer, a collagen copolymer (Staar surgical-V4b/c).
RESULTS: The mean age of the patients was 35.5 ± 1.35 years. At 12 months follow-up mean uncorrected distance visual acuity improved among the patients from 0.013 ± 0.04 preoperatively to 0.8 ± 0.45 postoperatively and the best corrected visual acuity from 0.8 ± 0.16 to 0.8 ± 0.3. Mean spherical equivalent decreased from -9.00 ± 4.68 D preoperatively to 0.12 ± 1.94 D postoperatively. A statistically significant difference in the intraocular pressure (IOP) was not observed (p = 0.3). The central distance between the posterior surface of the lens and the anterior surface of the pIOL (vault) was 0.45 ± 0.49 mm (minimum 0.064 mm, maximum 3.706 mm). Despite the AquaPORT a 28-year-old white woman suffered from a high postoperative IOP of 42 mmHg in both eyes and an ICL with diameter of 12.6 mm was substituted by an ICL with diameter 13.2 mm without complications.
CONCLUSION: The implantation of an ICL with AquaPORT technology provides a reliable alternative with good postoperative visual quality to all patients with high myopia when corneal refractive surgery is not possible. In order to enable early detection and treatment of increases in IOP due to angle block, regular postoperative IOP measurements are recommended.

Entities:  

Mesh:

Year:  2015        PMID: 25668710     DOI: 10.1007/s00347-015-3237-y

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  27 in total

1.  Posterior chamber collagen copolymer phakic intraocular lenses to correct myopia: five-year follow-up.

Authors:  José F Alfonso; Begoña Baamonde; Luis Fernández-Vega; Paulo Fernandes; Jose M González-Méijome; Robert Montés-Micó
Journal:  J Cataract Refract Surg       Date:  2011-05       Impact factor: 3.351

Review 2.  [Phakic intraocular lenses. Current status and limitations].

Authors:  H B Dick; M Tehrani
Journal:  Ophthalmologe       Date:  2004-03       Impact factor: 1.059

3.  Cataract surgery and IOL implantation. More than 40 years of personal experience. My present criteria and considerations.

Authors:  J Barraquer
Journal:  Doc Ophthalmol       Date:  1992       Impact factor: 2.379

4.  Optimizing the vault of collagen copolymer phakic intraocular lenses in eyes with keratoconus and myopia: comparison of 2 methods.

Authors:  Brian S Boxer Wachler; Lorelei L Vicente
Journal:  J Cataract Refract Surg       Date:  2010-07-31       Impact factor: 3.351

5.  Visual performance after posterior chamber phakic intraocular lens implantation and wavefront-guided laser in situ keratomileusis for low to moderate myopia.

Authors:  Kazutaka Kamiya; Akihito Igarashi; Kimiya Shimizu; Kazuhiro Matsumura; Mari Komatsu
Journal:  Am J Ophthalmol       Date:  2012-02-23       Impact factor: 5.258

Review 6.  The posterior chamber phakic refractive lens (PRL): a review.

Authors:  R J Pérez-Cambrodí; D P Piñero; T Ferrer-Blasco; A Cerviño; R Brautaset
Journal:  Eye (Lond)       Date:  2012-12-07       Impact factor: 3.775

7.  U.S. Food and Drug Administration clinical trial of the Implantable Contact Lens for moderate to high myopia.

Authors:  Donald R Sanders; John A Vukich; Kimberley Doney; Monica Gaston
Journal:  Ophthalmology       Date:  2003-02       Impact factor: 12.079

8.  Clinical outcomes after implantation of a posterior chamber collagen copolymer phakic intraocular lens with a central hole for myopic correction.

Authors:  José F Alfonso; Carlos Lisa; Luis Fernández-Vega Cueto; Lurdes Belda-Salmerón; David Madrid-Costa; Robert Montés-Micó
Journal:  J Cataract Refract Surg       Date:  2013-06       Impact factor: 3.351

9.  [Intacsintracorneal ring segments in keratoconus].

Authors:  M El-Husseiny; T Tsintarakis; T Eppig; A Langenbucher; B Seitz
Journal:  Ophthalmologe       Date:  2013-09       Impact factor: 1.059

10.  Posterior vitreous detachment and retinal detachment after implantation of the Visian phakic implantable collamer lens.

Authors:  Mahfouth A Bamashmus; Seddique A Al-Salahim; Nabil A Tarish; Mahmoud F Saleh; Hatem A Mahmoud; Mohamed F Elanwar; Mohamed A Awadalla
Journal:  Middle East Afr J Ophthalmol       Date:  2013 Oct-Dec
View more
  3 in total

Review 1.  [Phakic intraocular lenses].

Authors:  T Kohnen; M Shajari
Journal:  Ophthalmologe       Date:  2016-06       Impact factor: 1.059

2.  [Intraocular pressure after implantation of an ICL with aquaport : Development of intraocular pressure after implantation of an ICL (model V4c) with aquaport without iridotomy].

Authors:  B Repplinger; T Kohnen
Journal:  Ophthalmologe       Date:  2018-01       Impact factor: 1.059

Review 3.  Analysis of perioperative problems related to intraocular Implantable Collamer Lens (ICL) implantation.

Authors:  Hao Zhang; Rui Gong; Xiaolan Zhang; Yingping Deng
Journal:  Int Ophthalmol       Date:  2022-06-22       Impact factor: 2.029

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.